SlideShare a Scribd company logo
1 of 10
Download to read offline
1
Lichen ruber verrucosus
in patients with chronic
venous insufficiency
Hana Zelenkova, M.D. Ph,D.
Private Clinic of Dermatovenereology,
DOST Svidnik, Slovakia
2
Chronic venous insufficiency
(CVI /CVO)
is a very common condition
of vayring severity, affecting 10 - 50% of
adult population
¾ of patients with CVO remain untreated
Pharmacological therapy is indicated
from the very first symptoms in order
to prevent progression
Pathological symptoms include oedema,
pain, heavy legs, cramps and cutaneous
changes
3
Lichen ruber verrucosus
Is very stressful for the patient
First treatment is provided usually after
severe changes and manifestations have
already occurred
Both genders are affected alike, but
women seek medical attention more often
The itching is unbearable, some patients
scratch the foci raw, and allegedly only
then feel partial relief
Clinical pattern - appears predominantly
on extensor areas of lower legs but also
on the ankles of patients suffering from
chronic venous insufficiency.
4
Lichen ruber verrucosus
(lichen planus hypertrophicus)
The most prominent clinical
manifestations include multiple firm
papule-like foci of pea size and
blending plaque-like foci in the size
of a human palm
Elevated foci show the nature of
hyperkeratosis verruciformis, and
are of purple-red to brown-red
colour, which appears mainly on
the margins, while towards the
centre the colour changes to
white (chalk hyperkeratosis).
5
Clinical manifestation
The manifestations itch
severely, and heal by forming
atrophic hyperpigmented
scars. In the areas affected by
verrucous lesions, chronic
irritation (scratching) may lead
to the development of
verrucous carcinoma. It is
therefore advisable to perform
a histological examination
6
Therapy
Systemic – should include topical antiflogistics
and corticoids together with occlusion and
compression dressings, retinoids, azelaic acid
Topical – venopharmacs, venotonics,
antihistamine drugs, exceptionally corticoids,
cyclosporine(?), Chlorochin (?) – secondary
undesired system effects
The therapy must respond to the extent of the
condition and the subjective trouble of the patient
Topical application of ointments or tinctures even
in combination with occlusion only brings partial
relief and is thus insufficient
7
Best effects are achieved with intra-focal
corticoid injections
The anamnesis must be thoroughly
inspected prior to injection!
Injection corticoids are contraindicated
in patients on oral anticoagulants, pregnant
women and are disputable in diabetics
Intrafocally administered 1-2 ml of drug
according to condition
One application is usually enough
If necessary, another dose is injected in 1
month
8
Lichen ruber verrucosus - Intra-focal
corticoid injections - before therapy
and after 1 session - 56–year-old female
before after
9
Lichen ruber verrucosus - Intra-focal corticoid
injections - before therapy and after 1 session
48-yer-old female, severely obese, treated
over 10 years due to lower leg oedema
before after
10
Conclusion
Lichen ruber verrucosus is a very
discomforting dermatosis, which is also
difficult to treat
In case of diagnostic problems opt
for histological examination (to
exclude malignancy)
Intrafocal application of corticoids is very
efficient
It brings instant relief and the pathology
is gradually reduced
It is up to the dermatologist and

More Related Content

What's hot (6)

Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
 
Hypertensive retinopathy
Hypertensive retinopathyHypertensive retinopathy
Hypertensive retinopathy
 
IE in the ccu
IE in the ccuIE in the ccu
IE in the ccu
 
Hydrocephalus after Subarachnoid Hemorrhage
Hydrocephalus after Subarachnoid HemorrhageHydrocephalus after Subarachnoid Hemorrhage
Hydrocephalus after Subarachnoid Hemorrhage
 
Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16
Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16
Retina 1 anatomy and diabetic retinopathy d r.k.n.jha-26.05.16
 
DIABETIC RETINOPATHY 2017
DIABETIC RETINOPATHY 2017DIABETIC RETINOPATHY 2017
DIABETIC RETINOPATHY 2017
 

Similar to EWMA 2013 - Ep511 - Lichen ruber verrucosus in patients with chronic venous insufficiency

Cutaneous Drug Adverse Reaction seminar.pptx
Cutaneous Drug Adverse Reaction seminar.pptxCutaneous Drug Adverse Reaction seminar.pptx
Cutaneous Drug Adverse Reaction seminar.pptxAlexXander53
 
Trends on management of superficial venous disease
Trends on management of superficial venous diseaseTrends on management of superficial venous disease
Trends on management of superficial venous diseaseShantonu Kumar Ghosh
 
sepsisandrationaluseofabx-200807073944.pptx
sepsisandrationaluseofabx-200807073944.pptxsepsisandrationaluseofabx-200807073944.pptx
sepsisandrationaluseofabx-200807073944.pptxVenoshaGunasekaran
 
Behcet disease (2)
Behcet disease (2)Behcet disease (2)
Behcet disease (2)Rajamarhamah
 
Cutaneous drug reactions
Cutaneous drug reactionsCutaneous drug reactions
Cutaneous drug reactionsDR RML DELHI
 
Cutaneous drug reactions
Cutaneous drug reactionsCutaneous drug reactions
Cutaneous drug reactionsDR RML DELHI
 
chapter 25 of everything everywhere- NSI.pptx
chapter 25 of everything everywhere- NSI.pptxchapter 25 of everything everywhere- NSI.pptx
chapter 25 of everything everywhere- NSI.pptxKhushalLahoti
 
Sepsis and rational use of abx
Sepsis and rational use of abxSepsis and rational use of abx
Sepsis and rational use of abxAfiqi Fikri
 
Contrast reactions
Contrast reactionsContrast reactions
Contrast reactionsSameer Peer
 
Posner Schlossman Syndrome
Posner Schlossman SyndromePosner Schlossman Syndrome
Posner Schlossman SyndromeEllaHassanLee
 
Hypersensitive drug reaction in children.pptx
Hypersensitive drug reaction in children.pptxHypersensitive drug reaction in children.pptx
Hypersensitive drug reaction in children.pptxSabonaLemessa2
 
Herpes Simplex Keratitis .pptx
Herpes Simplex Keratitis .pptxHerpes Simplex Keratitis .pptx
Herpes Simplex Keratitis .pptxAmeyTamhane
 
DRESS SYNDROME.pptx
DRESS SYNDROME.pptxDRESS SYNDROME.pptx
DRESS SYNDROME.pptxLahariNaidu7
 
lupus nephritis
lupus nephritislupus nephritis
lupus nephritisKushal Dp
 
MALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptxMALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptxJibinJames35
 

Similar to EWMA 2013 - Ep511 - Lichen ruber verrucosus in patients with chronic venous insufficiency (20)

Cutaneous Drug Adverse Reaction seminar.pptx
Cutaneous Drug Adverse Reaction seminar.pptxCutaneous Drug Adverse Reaction seminar.pptx
Cutaneous Drug Adverse Reaction seminar.pptx
 
Trends on management of superficial venous disease
Trends on management of superficial venous diseaseTrends on management of superficial venous disease
Trends on management of superficial venous disease
 
sepsisandrationaluseofabx-200807073944.pptx
sepsisandrationaluseofabx-200807073944.pptxsepsisandrationaluseofabx-200807073944.pptx
sepsisandrationaluseofabx-200807073944.pptx
 
Behcet disease (2)
Behcet disease (2)Behcet disease (2)
Behcet disease (2)
 
Viral Skin Infections.pptx
Viral Skin Infections.pptxViral Skin Infections.pptx
Viral Skin Infections.pptx
 
Cutaneous drug reactions
Cutaneous drug reactionsCutaneous drug reactions
Cutaneous drug reactions
 
Cutaneous drug reactions
Cutaneous drug reactionsCutaneous drug reactions
Cutaneous drug reactions
 
chapter 25 of everything everywhere- NSI.pptx
chapter 25 of everything everywhere- NSI.pptxchapter 25 of everything everywhere- NSI.pptx
chapter 25 of everything everywhere- NSI.pptx
 
Sepsis and rational use of abx
Sepsis and rational use of abxSepsis and rational use of abx
Sepsis and rational use of abx
 
Contrast reactions
Contrast reactionsContrast reactions
Contrast reactions
 
Posner Schlossman Syndrome
Posner Schlossman SyndromePosner Schlossman Syndrome
Posner Schlossman Syndrome
 
Medical management of uveitis
Medical  management  of uveitisMedical  management  of uveitis
Medical management of uveitis
 
Antiviral drugs
Antiviral drugsAntiviral drugs
Antiviral drugs
 
Hypersensitive drug reaction in children.pptx
Hypersensitive drug reaction in children.pptxHypersensitive drug reaction in children.pptx
Hypersensitive drug reaction in children.pptx
 
Herpes Simplex Keratitis .pptx
Herpes Simplex Keratitis .pptxHerpes Simplex Keratitis .pptx
Herpes Simplex Keratitis .pptx
 
DRESS SYNDROME.pptx
DRESS SYNDROME.pptxDRESS SYNDROME.pptx
DRESS SYNDROME.pptx
 
Herpetic eye disease
Herpetic eye diseaseHerpetic eye disease
Herpetic eye disease
 
lupus nephritis
lupus nephritislupus nephritis
lupus nephritis
 
MALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptxMALIGNANT PLEURAL EFFUSION..pptx
MALIGNANT PLEURAL EFFUSION..pptx
 
Anti-VEGF. Facts&Myths
Anti-VEGF. Facts&MythsAnti-VEGF. Facts&Myths
Anti-VEGF. Facts&Myths
 

More from EWMA

EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...EWMA
 
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...EWMA
 
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...EWMA
 
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...EWMA
 
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...EWMA
 
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...EWMA
 
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...EWMA
 
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...EWMA
 
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...EWMA
 
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...EWMA
 
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...EWMA
 
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...EWMA
 
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...EWMA
 
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...EWMA
 
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTSEWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTSEWMA
 
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...EWMA
 
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...EWMA
 
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...EWMA
 
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...EWMA
 
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...EWMA
 

More from EWMA (20)

EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
EWMA 2014 - EP502 A LABORATORY EVALUATION OF THE BLOOD ABSORPTION PROPERTIES ...
 
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
EWMA 2014 - EP500 VENOUS ULCER RELAPSE EPITHELIZATION FOLLOWING AN EDEMA REDU...
 
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
EWMA 2014 - EP499 MANAGEMENT OF AN INFECTED DIABETIC FOOT WITH SPECIALIZED DR...
 
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
EWMA 2014 - EP498 USE OF NEGATIVE PRESSURE THERAPY IN CONJUNCTION WITH A PROT...
 
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
EWMA 2014 - EP496 CONTEMPORARY SILVER DRESSINGS IN THE TREATMENT OF INFECTED ...
 
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
EWMA 2014 - EP495 TOTAL CONTACT CASTING – A SOUTH AFRICAN APPROACH TOWARDS OF...
 
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
Ep4EWMA 2014 - EP493 GAIT ALTERATIONS AND MICROVASCULAR CHRONIC COMPLICATIONS...
 
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
EWMA 2014 - EP492 PREVALENCE OF DIABETIC RETINOPATHY (DR) AND ITS CORRELATION...
 
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
EWMA 2014 - EP491 DETECTION OF RISK FACTORS CONCERNING DIABETIC FOOT (DF) THR...
 
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
EWMA 2014 - EP490 THE CHARACTERISTICS OF WOUND PAIN ASSOCIATED WITH DIABETES-...
 
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
EWMA 2014 - EP489 PERIPHERAL ARTERIAL DISEASE IN DIABETIC PATIENTS WHO NEED A...
 
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
EWMA 2014 - EP488 THE COMBINATION OF THE HYDROACTIVE OINTMENT BANDAGE* AND TH...
 
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
EWMA 2014 - EP487 KIDNEY-FOOT SYNDROME: OUTCOMES AFTER PTA IN EP487 KIDNEY-FO...
 
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
EWMA 2014 - EP486 THE USE OF BIOSYNTHETIC BANDAGES «HYDROBALANCE-BANDAGE» (HB...
 
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTSEWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
EWMA 2014 - EP485 EVALUATION OF MR ANGIOGRAPHY RESULTS IN DIABETIC FOOT PATIENTS
 
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
EWMA 2014 - EP483 THE EFFECTS OF DIABETIC FOOT ULCER (DFU) WOUND FLUID PH ON ...
 
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
EWMA 2014 - EP482 COMPARISON OF ANGIOGRAPHIC FINDINGS BETWEEN PATIENTS WITH N...
 
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
EWMA 2014 - EP477 EVALUATION OF FOOT SELF CARE KNOWLEDGE AND PRACTICES IN SAU...
 
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
EWMA 2014 - EP476 DIABETIC FOOT ULCER HEALING IN RELATIONSHIP WITH INITIAL TR...
 
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
EWMA 2014 - EP475 ANALYSIS OF MICROBIOTA IN DIABETIC FOOT ULCERS IN RELATION ...
 

Recently uploaded

Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...
Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...
Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...Call Girls in Nagpur High Profile Call Girls
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019Akash Agnihotri
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsMedicoseAcademics
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examJunhao Koh
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsNaveen Gokul Dr
 
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalTreatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalGokuldas Hospital
 
Quality control tests of suppository ...
Quality control tests  of suppository ...Quality control tests  of suppository ...
Quality control tests of suppository ...Hasnat Tariq
 
DR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in IndiaDR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in IndiaNehamehta128467
 
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxGross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxDr. Rabia Inam Gandapore
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSachin Sharma
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxDr. Sohan Biswas
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifierNidhi Joshi
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Stepdarmandersingh4580
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failuremahiavy26
 
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...anushka vermaI11
 
Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...
Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...
Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...anushka vermaI11
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stocktammysayles9
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptxclaviclebrown44
 

Recently uploaded (20)

Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...
Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...
Young & Hot ℂall Girls Salem 8250077686 WhatsApp Number Best Rates of Surat ℂ...
 
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
NDCT Rules, 2019: An Overview | New Drugs and Clinical Trial Rules 2019
 
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose AcademicsConnective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
Connective Tissue II - Dr Muhammad Ali Rabbani - Medicose Academics
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancementsCAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
CAD CAM DENTURES IN PROSTHODONTICS : Dental advancements
 
Treatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas HospitalTreatment Choices for Slip Disc at Gokuldas Hospital
Treatment Choices for Slip Disc at Gokuldas Hospital
 
Quality control tests of suppository ...
Quality control tests  of suppository ...Quality control tests  of suppository ...
Quality control tests of suppository ...
 
DR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in IndiaDR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in India
 
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptxGross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
Gross Anatomy and Histology of Tongue by Dr. Rabia Inam Gandapore.pptx
 
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdfSEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
SEMESTER-V CHILD HEALTH NURSING-UNIT-1-INTRODUCTION.pdf
 
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptxANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
ANAPHYLAXIS BY DR.SOHAN BISWAS,MBBS,DNB(INTERNAL MEDICINE) RESIDENT.pptx
 
The Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - SubconsciousThe Clean Living Project Episode 24 - Subconscious
The Clean Living Project Episode 24 - Subconscious
 
Overview on the Automatic pill identifier
Overview on the Automatic pill identifierOverview on the Automatic pill identifier
Overview on the Automatic pill identifier
 
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door StepBangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
Bangalore whatsapp Number Just VIP Brookefield 100% Genuine at your Door Step
 
ESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failureESC HF 2024 Spotlights Day-2.pptx heart failure
ESC HF 2024 Spotlights Day-2.pptx heart failure
 
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
Vesu + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7 C...
 
Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...
Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...
Kamrej + ℂall Girls Serviℂe Surat (Adult Only) 8849756361 Esℂort Serviℂe 24x7...
 
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
Best medicine 100% Effective&Safe Mifepristion ௵+918133066128௹Abortion pills ...
 
Sell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stockSell 5cladba adbb JWH-018 5FADB in stock
Sell 5cladba adbb JWH-018 5FADB in stock
 
Failure to thrive in neonates and infants + pediatric case.pptx
Failure to thrive in neonates and infants  + pediatric case.pptxFailure to thrive in neonates and infants  + pediatric case.pptx
Failure to thrive in neonates and infants + pediatric case.pptx
 

EWMA 2013 - Ep511 - Lichen ruber verrucosus in patients with chronic venous insufficiency

  • 1. 1 Lichen ruber verrucosus in patients with chronic venous insufficiency Hana Zelenkova, M.D. Ph,D. Private Clinic of Dermatovenereology, DOST Svidnik, Slovakia
  • 2. 2 Chronic venous insufficiency (CVI /CVO) is a very common condition of vayring severity, affecting 10 - 50% of adult population ¾ of patients with CVO remain untreated Pharmacological therapy is indicated from the very first symptoms in order to prevent progression Pathological symptoms include oedema, pain, heavy legs, cramps and cutaneous changes
  • 3. 3 Lichen ruber verrucosus Is very stressful for the patient First treatment is provided usually after severe changes and manifestations have already occurred Both genders are affected alike, but women seek medical attention more often The itching is unbearable, some patients scratch the foci raw, and allegedly only then feel partial relief Clinical pattern - appears predominantly on extensor areas of lower legs but also on the ankles of patients suffering from chronic venous insufficiency.
  • 4. 4 Lichen ruber verrucosus (lichen planus hypertrophicus) The most prominent clinical manifestations include multiple firm papule-like foci of pea size and blending plaque-like foci in the size of a human palm Elevated foci show the nature of hyperkeratosis verruciformis, and are of purple-red to brown-red colour, which appears mainly on the margins, while towards the centre the colour changes to white (chalk hyperkeratosis).
  • 5. 5 Clinical manifestation The manifestations itch severely, and heal by forming atrophic hyperpigmented scars. In the areas affected by verrucous lesions, chronic irritation (scratching) may lead to the development of verrucous carcinoma. It is therefore advisable to perform a histological examination
  • 6. 6 Therapy Systemic – should include topical antiflogistics and corticoids together with occlusion and compression dressings, retinoids, azelaic acid Topical – venopharmacs, venotonics, antihistamine drugs, exceptionally corticoids, cyclosporine(?), Chlorochin (?) – secondary undesired system effects The therapy must respond to the extent of the condition and the subjective trouble of the patient Topical application of ointments or tinctures even in combination with occlusion only brings partial relief and is thus insufficient
  • 7. 7 Best effects are achieved with intra-focal corticoid injections The anamnesis must be thoroughly inspected prior to injection! Injection corticoids are contraindicated in patients on oral anticoagulants, pregnant women and are disputable in diabetics Intrafocally administered 1-2 ml of drug according to condition One application is usually enough If necessary, another dose is injected in 1 month
  • 8. 8 Lichen ruber verrucosus - Intra-focal corticoid injections - before therapy and after 1 session - 56–year-old female before after
  • 9. 9 Lichen ruber verrucosus - Intra-focal corticoid injections - before therapy and after 1 session 48-yer-old female, severely obese, treated over 10 years due to lower leg oedema before after
  • 10. 10 Conclusion Lichen ruber verrucosus is a very discomforting dermatosis, which is also difficult to treat In case of diagnostic problems opt for histological examination (to exclude malignancy) Intrafocal application of corticoids is very efficient It brings instant relief and the pathology is gradually reduced It is up to the dermatologist and